ERBB2 and neoplasm: Considering a large database of 435 patients including all tumour phenotypes (HER2, Luminal, TN), Lee et al. [21] observed better classification performances when clinicopathological information was combined with texture parameters from 18F-FDG PET scans, albeit not significantly.